{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:17:22Z","timestamp":1792603042945,"version":"4.5.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T00:00:00Z","timestamp":1768694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Mol and Cell Biol"],"DOI":"10.1186\/s12860-026-00565-z","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:15:21Z","timestamp":1768709721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dysregulation of caspase-8 and caspase-9 in T-lymphocyte apoptosis: implications for pathogenesis, diagnosis, and therapeutic targeting in psoriatic arthritis"],"prefix":"10.1186","volume":"27","author":[{"given":"Hadeel A.","family":"Al-Rawaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami A.","family":"Gabr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad H.","family":"Alghadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,18]]},"reference":[{"key":"565_CR1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1600-0625.2007.00629.x","volume":"16","author":"R Sabat","year":"2007","unstructured":"Sabat R, Philipp S, H\u00f6flich C, et al. Immunopathogenesis of psoriasis. Exp Dermatol. 2007;16:779\u201398.","journal-title":"Exp Dermatol"},{"key":"565_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/0019-5154.48977","volume":"54","author":"RP Das","year":"2009","unstructured":"Das RP, Jain AK, Ramesh V. Current concepts in the pathogenesis of psoriasis. Indian J Dermatol. 2009;54:7\u201312.","journal-title":"Indian J Dermatol"},{"issue":"8","key":"565_CR3","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3390\/genes14081619","volume":"14","author":"L Mateu-Arrom","year":"2023","unstructured":"Mateu-Arrom L, Puig L. Genetic and epigenetic mechanisms of psoriasis. Genes. 2023;14(8):1619.","journal-title":"Genes"},{"issue":"1","key":"565_CR4","doi-asserted-by":"publisher","first-page":"19313","DOI":"10.1038\/s41598-023-46795-5","volume":"13","author":"L Yang","year":"2023","unstructured":"Yang L, Zhang L, Du Q, Gong X, Tian J. Exploring the molecular mechanism underlying the psoriasis and T2D by using microarray data analysis. Sci Rep. 2023;13(1):19313.","journal-title":"Sci Rep"},{"key":"565_CR5","doi-asserted-by":"crossref","unstructured":"Wu M, Dai C, Zeng F. Cellular mechanisms of psoriasis pathogenesis: a systemic review. Clin Cosmet Invest Dermatology, 2023; 2503\u201315.","DOI":"10.2147\/CCID.S420850"},{"issue":"10281","key":"565_CR6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J, Psoriasis. Lancet. 2021;397(10281):1301\u201315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6.","journal-title":"Lancet"},{"issue":"2","key":"565_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"IM Michalek","year":"2017","unstructured":"Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205\u201312. https:\/\/doi.org\/10.1111\/jdv.13854.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"565_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/1744666X.2020.1719833","volume":"16","author":"E Pezzolo","year":"2020","unstructured":"Pezzolo E, Naldi L. Epidemiology of major chronic inflammatory immune-related skin diseases in 2019. Expert Rev Clin Immunol. 2020;16(2):155\u201366. https:\/\/doi.org\/10.1080\/1744666X.2020.1719833.","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"565_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1590\/abd1806-4841.20164169","volume":"91","author":"J Machado-Pinto","year":"2016","unstructured":"Machado-Pinto J, Diniz Mdos S, Bavoso NC. Psoriasis: new comorbidities. Bras Dermatol. 2016;91(1):8\u201314. https:\/\/doi.org\/10.1590\/abd1806-4841.20164169.","journal-title":"Bras Dermatol"},{"issue":"3","key":"565_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377\u201390. https:\/\/doi.org\/10.1016\/j.jaad.2016.07.064.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"565_CR11","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/ijd.14032","volume":"57","author":"L Rousset","year":"2018","unstructured":"Rousset L, Halioua B. Stress and psoriasis. Int J Dermatol. 2018;57(10):1165\u201372. https:\/\/doi.org\/10.1111\/ijd.14032.","journal-title":"Int J Dermatol"},{"issue":"3","key":"565_CR12","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/bjd.15021","volume":"176","author":"DA Springate","year":"2017","unstructured":"Springate DA, Parisi R, Kontopantelis E, Reeves D, Griffiths CE, Ashcroft DM. Incidence, prevalence and mortality of patients with psoriasis: a UK population-based cohort study. Br J Dermatol. 2017;176(3):650\u20138. https:\/\/doi.org\/10.1111\/bjd.15021.","journal-title":"Br J Dermatol"},{"issue":"19","key":"565_CR13","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945\u201360. https:\/\/doi.org\/10.1001\/jama.2020.","journal-title":"JAMA"},{"key":"565_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJM200108023450506","volume":"345","author":"A Davidson","year":"2001","unstructured":"Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345:340\u201350.","journal-title":"N Engl J Med"},{"key":"565_CR15","doi-asserted-by":"crossref","unstructured":"Bu J, Ding R, Zhou L, Chen X, Shen E. Epidemiology of psoriasis and comorbid diseases: a narrative review. Front Immunol.2022; 13(880201).","DOI":"10.3389\/fimmu.2022.880201"},{"key":"565_CR16","doi-asserted-by":"crossref","unstructured":"Weber B, Merola JF, Husni ME, Di Carli M, Berger JS, Garshick MS. Psoriasis and cardiovascular disease: novel mechanisms and evolving therapeutics. Curr Atheroscler Rep. 2021; 23(67).","DOI":"10.1007\/s11883-021-00963-y"},{"key":"565_CR17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/1346-8138.15840","volume":"48","author":"F Yamazaki","year":"2021","unstructured":"Yamazaki F. Psoriasis: comorbidities. J Dermatol. 2021;48:732\u201340.","journal-title":"J Dermatol"},{"issue":"Suppl2","key":"565_CR18","doi-asserted-by":"publisher","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","volume":"64","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis; epidemiology, clinical features, course, and outcomes. Ann Rheum Dis. 2005;64(Suppl2):ii14\u201317.","journal-title":"Ann Rheum Dis"},{"key":"565_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/ard.2008.090548","volume":"69","author":"AW van Kuijk","year":"2010","unstructured":"van Kuijk AW, Wijbrandts CA, Vinkenoog M, et al. TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumor necrosis factor Blockade. Ann Rheum Dis. 2010;69:301\u20134.","journal-title":"Ann Rheum Dis"},{"key":"565_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cyto.2010.12.003","volume":"53","author":"L Xia","year":"2011","unstructured":"Xia L, Shen H, Xiao W, et al. Increased serum TWEAK levels in psoriatic arthritis: relationship with disease activity and matrix metalloproteinase-3 serum levels. Cytokine. 2011;53:289\u201391.","journal-title":"Cytokine"},{"key":"565_CR21","doi-asserted-by":"publisher","first-page":"e12556","DOI":"10.1371\/journal.pone.0012556","volume":"5","author":"AW van Kuijk","year":"2010","unstructured":"van Kuijk AW, DeGroot J, Koeman RC, et al. Soluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placebo. PLoS One. 2010;5:e12556.","journal-title":"PLoS One"},{"key":"565_CR22","doi-asserted-by":"publisher","first-page":"R164","DOI":"10.1186\/ar3123","volume":"12","author":"N Dalbeth","year":"2010","unstructured":"Dalbeth N, Pool B, Smith T, et al. Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. Arthritis Res Ther. 2010;12:R164.","journal-title":"Arthritis Res Ther"},{"key":"565_CR23","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.3390\/ijms20184347","volume":"20","author":"K Kamiya","year":"2019","unstructured":"Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019;20:4347.","journal-title":"Int J Mol Sci"},{"key":"565_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2340\/00015555-3384","volume":"100","author":"N Dand","year":"2020","unstructured":"Dand N, Mahil SK, Capon F, Smith CH, Simpson MA, Barker JN. Psoriasis and genetics. Acta Derm Venereol. 2020;100:54\u201364.","journal-title":"Acta Derm Venereol"},{"key":"565_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/1389202923666220527111037","volume":"23","author":"F Babaie","year":"2022","unstructured":"Babaie F, Omraninava M, Gorabi AM, Khosrojerdi A, Aslani S, Yazdchi A, Torkamandi S, Mikaeili H, Sathyapalan T, Sahebkar A. Etiopathogenesis of psoriasis from genetic perspective: an updated review. Curr Genom. 2022;23:163\u201374.","journal-title":"Curr Genom"},{"key":"565_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12016-022-08956-8","volume":"63","author":"F Gibson","year":"2022","unstructured":"Gibson F, Hanly A, Grbic N, Grunberg N, Wu M, Collard M, Alani RM. Epigenetic dysregulation in autoimmune and inflammatory skin diseases. Clin Rev Allergy Immunol. 2022;63:447\u201371.","journal-title":"Clin Rev Allergy Immunol"},{"key":"565_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/107999003766628124","volume":"23","author":"MJ Clemens","year":"2003","unstructured":"Clemens MJ. Interferons and apoptosis. J Interferon Cytokine Res. 2003;23:277\u201392.","journal-title":"J Interferon Cytokine Res"},{"key":"565_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000018394","volume":"200","author":"M Laporte","year":"2000","unstructured":"Laporte M, Galand P, Fokan D, et al. Apoptosis in established and healing psoriasis. Dermatology. 2000;200:314\u20136.","journal-title":"Dermatology"},{"key":"565_CR29","first-page":"79","volume":"14","author":"W Baran","year":"2005","unstructured":"Baran W, Szepietowski JC, Szybejko-Machaj G. Expression of p53 protein in psoriasis. Acta Dermatovenerol Alp Panonica Adriat. 2005;14:79\u201383.","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"565_CR30","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1046\/j.1365-4362.2003.01821.x","volume":"42","author":"M Ko\u00e7ak","year":"2003","unstructured":"Ko\u00e7ak M, Bozdogan O, Erkek E, Atasoy P, Birol A. Examination of Bcl-2, Bcl-X and Bax protein expression in psoriasis. Int J Dermatol. 2003;42:789\u201393.","journal-title":"Int J Dermatol"},{"key":"565_CR31","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1046\/j.1471-4159.2002.00859.x","volume":"81","author":"J Tucholski","year":"2002","unstructured":"Tucholski J, Johnson GV. Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner. J Neurochem. 2002;81:780\u201391.","journal-title":"J Neurochem"},{"key":"565_CR32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00403-012-1230-8","volume":"304","author":"SA Gabr","year":"2012","unstructured":"Gabr SA, Al-Ghadir AH. Role of cellular oxidative stress and cytochrome c in the pathogenesis of psoriasis. Arch Dermatol Res. 2012;304:451\u20137.","journal-title":"Arch Dermatol Res"},{"key":"565_CR33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4103\/0019-5154.131377","volume":"59","author":"SA Gabr","year":"2014","unstructured":"Gabr SA, Berika MA, Alghadir AH. Apoptosis and clinical severity in patients with psoriasis and HCV infection. Indian J Dermatol. 2014;59:230\u20136.","journal-title":"Indian J Dermatol"},{"issue":"Suppl","key":"565_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/1523-1747.ep12876121","volume":"94","author":"JG Krueger","year":"1990","unstructured":"Krueger JG, Krane JF, Carter DM, Gottlieb AB. Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol. 1990;94(Suppl):135\u201340.","journal-title":"J Invest Dermatol"},{"key":"565_CR35","first-page":"422","volume":"86","author":"N Mozzanica","year":"1995","unstructured":"Mozzanica N, Cattaneo A, Trabattoni D, et al. Production of type-1 and type-2 cytokines by peripheral blood mononuclear cells of psoriatic patients. Immunology. 1995;86:422\u20136.","journal-title":"Immunology"},{"key":"565_CR36","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/j.0022-202X.2005.23864.x","volume":"125","author":"KW Eriksen","year":"2005","unstructured":"Eriksen KW, Lovato P, Skov L, et al. Increased sensitivity to interferon-alpha in psoriatic T cells. J Invest Dermatol. 2005;125:936\u201344.","journal-title":"J Invest Dermatol"},{"key":"565_CR37","first-page":"14","volume":"211","author":"L Prpi\u0107","year":"2000","unstructured":"Prpi\u0107 L, Strbo N, Sotosek V, Gruber F, Podack ER, Rukavina D. Assessment of Perforin expression in peripheral blood lymphocytes in psoriatic patients during exacerbation of disease. Acta Derm Venereol Suppl (Stockh). 2000;211:14\u20136.","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"565_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jdermsci.2007.02.007","volume":"47","author":"ML Prpi\u0107","year":"2007","unstructured":"Prpi\u0107 ML, Kastelan M, Laskarin G, Zamolo G, Massari D, Rukavina D. Analysis of Perforin expression in peripheral blood and lesions in severe and mild psoriasis. J Dermatol Sci. 2007;47:29\u201336.","journal-title":"J Dermatol Sci"},{"key":"565_CR39","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1096\/fj.02-1070com","volume":"17","author":"M Akdis","year":"2003","unstructured":"Akdis M, Trautmann A, Klunker S, et al. T helper (Th) 2 predominance in atopic diseases is due to Preferential apoptosis of Circulating memory\/ effector Th1 cells. FASEB J. 2003;17:1026\u201335.","journal-title":"FASEB J"},{"issue":"Suppl 7","key":"565_CR40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1086\/431998","volume":"41","author":"RS Hotchkiss","year":"2005","unstructured":"Hotchkiss RS, Coopersmith CM, Karl IE. Prevention of lymphocyte apoptosis\u2013a potential treatment of sepsis? Clin Infect Dis. 2005;41(Suppl 7):465\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"565_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI9199","volume":"106","author":"A Trautmann","year":"2000","unstructured":"Trautmann A, Akdis M, Kleemann D, et al. T cell\u2013mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Investig. 2000;106(1):25\u201335.","journal-title":"J Clin Investig"},{"issue":"12","key":"565_CR42","first-page":"815","volume":"127","author":"J Bartosi\u0144ska","year":"2017","unstructured":"Bartosi\u0144ska J, Zakrzewska E, Kr\u00f3l A, et al. Differential expression of programmed death 1 (PD-1) on CD4\u2009+\u2009and CD8\u2009+\u2009T cells in rheumatoid arthritis and psoriatic arthritis. Pol Arch Intern Med. 2017;127(12):815\u201322.","journal-title":"Pol Arch Intern Med"},{"issue":"1","key":"565_CR43","doi-asserted-by":"publisher","first-page":"20675","DOI":"10.1038\/s41598-022-24924-w","volume":"12","author":"JN Pouw","year":"2022","unstructured":"Pouw JN, Olde Nordkamp MA, van Kempen T, et al. Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161\u2009+\u2009ROR\u03b3t\u2009+\u2009ICOS\u2009+\u2009phenotype, that associates with the presence of ADAMTSL5 autoantibodies. Sci Rep. 2022;12(1):20675.","journal-title":"Sci Rep"},{"key":"565_CR44","doi-asserted-by":"crossref","unstructured":"Jiang Q, Yang G, Liu Q, Wang S, Cui D. Function and role of regulatory T cells in rheumatoid arthritis. Front Immunol 202;12:626193.","DOI":"10.3389\/fimmu.2021.626193"},{"issue":"3","key":"565_CR45","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/jid.2010.370","volume":"131","author":"ML Salskov-Iversen","year":"2011","unstructured":"Salskov-Iversen ML, Johansen C, Kragballe K, Iversen L. Caspase-5 expression is upregulated in lesional psoriatic skin. J Invest Dermatology. 2011;131(3):670\u20136.","journal-title":"J Invest Dermatology"},{"issue":"12","key":"565_CR46","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1038\/sj.jid.5700922","volume":"127","author":"C Johansen","year":"2007","unstructured":"Johansen C, Moeller K, Kragballe K, Iversen L. The activity of caspase-1 is increased in lesional psoriatic epidermis. J Invest Dermatology. 2007;127(12):2857\u201364.","journal-title":"J Invest Dermatology"},{"issue":"3","key":"565_CR47","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jid.2020.07.012","volume":"141","author":"D Verma","year":"2021","unstructured":"Verma D, Fekri SZ, Sigurdardottir G, Eding CB, Sandin C, Enerb\u00e4ck C. Enhanced inflammasome activity in patients with psoriasis promotes systemic inflammation. J Invest Dermatology. 2021;141(3):586\u201395.","journal-title":"J Invest Dermatology"},{"key":"565_CR48","doi-asserted-by":"crossref","unstructured":"W\u00f3jcik P, \u0141uczaj W, Zarkovic N, Skrzydlewska E. Modulation of oxidative stress in psoriasis: pathophysiology and therapy. Modulation of oxidative stress. Academic; 2023. pp. 255\u201378.","DOI":"10.1016\/B978-0-443-19247-0.00014-X"},{"issue":"12","key":"565_CR49","doi-asserted-by":"publisher","first-page":"813","DOI":"10.20452\/pamw.4172","volume":"127","author":"W Murray-Brown","year":"2017","unstructured":"Murray-Brown W, Wechalekar MD, Smith M. PD-1\u2009+\u2009T cells contribute differently to the pathogenesis of rheumatoid arthritis and psoriatic arthritis. Pol Arch Intern Med. 2017;127(12):813\u20134. https:\/\/doi.org\/10.20452\/pamw.4172.","journal-title":"Pol Arch Intern Med"},{"key":"565_CR50","doi-asserted-by":"crossref","unstructured":"Pouw JN, Nordkamp MA, van Kempen T, et al. Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3 (int) CD161+ ROR gamma t plus ICOS plus phenotype, that associates with the presence of ADAMTSL5 autoantibodies. Scientific Reports. 2022 Nov 30;12(1).","DOI":"10.1038\/s41598-022-24924-w"},{"issue":"9","key":"565_CR51","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1136\/annrheumdis-2021-221761","volume":"81","author":"A Floudas","year":"2022","unstructured":"Floudas A, Smith CM, Tynan O, et al. Distinct stromal and immune cell interactions shape the pathogenesis of rheumatoid and psoriatic arthritis. Ann Rheum Dis. 2022;81(9):1224\u201342.","journal-title":"Ann Rheum Dis"},{"key":"565_CR52","unstructured":"Hashemi R, Majidi A, Motamed H, Amini A, Najari F, Tabatabaey A. Erythrocyte sedimentation rate measurement using as a rapid alternative to the Westergren Method. Emerg (Tehran). 2015 Spring;3(2):50\u20133."},{"key":"565_CR53","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665\u201373.","journal-title":"Arthritis Rheum"},{"key":"565_CR54","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1002\/art.22843","volume":"56","author":"RH Mullan","year":"2007","unstructured":"Mullan RH, Matthews C, Bresnihan B, et al. Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy. Arthritis Rheum. 2007;56:2919\u201328.","journal-title":"Arthritis Rheum"},{"key":"565_CR55","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/acr.20265","volume":"62","author":"J Anderson","year":"2010","unstructured":"Anderson J, Sayles H, Curtis JR, et al. Converting modified health assessment questionnaire (HAQ), multidimensional HAQ, and HAQII scores into original HAQ scores using models developed with a large cohort of rheumatoid arthritis patients. Arthritis Care Res (Hoboken). 2010;62:1481\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"565_CR56","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/ard.2006.054205","volume":"66","author":"E Inoue","year":"2007","unstructured":"Inoue E, Yamanaka H, Hara M, et al. Comparison of disease activity score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values. Ann Rheum Dis. 2007;66:407\u20139.","journal-title":"Ann Rheum Dis"},{"key":"565_CR57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5070\/D318W9J736","volume":"10","author":"BA Louden","year":"2004","unstructured":"Louden BA, Pearce DJ, Lang W, Feldman SR. A simplified psoriasis area severity index (SPASI) for rating psoriasis severity in clinical patients. Dermatol Online J. 2004;10:17.","journal-title":"Dermatol Online J"},{"key":"565_CR58","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1042\/BJ20040809","volume":"382","author":"KM Boatright","year":"2004","unstructured":"Boatright KM, Deis C, Denault JB, Sutherlin DP, Salvasen GS. Activation of caspases-8 and 10 by FLIP (L). Biochem J. 2004;382:651\u20137.","journal-title":"Biochem J"},{"key":"565_CR59","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1357-2725(99)00024-2","volume":"32","author":"K Kuida","year":"2000","unstructured":"Kuida K. Caspase-9. Int J Biochem Cell Biol. 2000;32:121\u20134.","journal-title":"Int J Biochem Cell Biol"},{"key":"565_CR60","doi-asserted-by":"publisher","first-page":"8091","DOI":"10.1074\/jbc.M204783200","volume":"278","author":"H Zou","year":"2003","unstructured":"Zou H, Yang R, Hao J, et al. Regulation of the Apaf-1\/caspase-9 apoptosome by caspase-3 and XIAP. J Bio Chem. 2003;278:8091\u20138.","journal-title":"J Bio Chem"},{"issue":"8","key":"565_CR61","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.cellbi.2005.04.005","volume":"29","author":"U Ergun","year":"2005","unstructured":"Ergun U, Yurtcu E, Ergun MA. Protective effect of Ginkgo Biloba against Gossypolinduced apoptosis in human lymphocytes. Cell Biol Int. 2005;29(8):717\u201320.","journal-title":"Cell Biol Int"},{"issue":"9","key":"565_CR62","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3390\/life12091427","volume":"12","author":"SA Gabr","year":"2022","unstructured":"Gabr SA, Elsaed WM, Eladl MA, El-Sherbiny M, Ebrahim HA, Asseri SM, Eltahir YA, Elsherbiny N, Eldesoqui M. Curcumin modulates oxidative stress, fibrosis, and apoptosis in drug-resistant cancer cell lines. Life. 2022;12(9):1427.","journal-title":"Life"},{"key":"565_CR63","doi-asserted-by":"publisher","first-page":"391e8","DOI":"10.1016\/S0145-2126(01)00147-3","volume":"26","author":"S Yuksel","year":"2002","unstructured":"Yuksel S, Saydam G, Uslu R, et al. Arsenic trioxide and Methylprednisolone use different signal transduction pathways in leukemic differentiation. Leuk Res. 2002;26:391e8.","journal-title":"Leuk Res"},{"issue":"3","key":"565_CR64","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood.V87.3.1113.bloodjournal8731113","volume":"87","author":"R Roger","year":"1996","unstructured":"Roger R, Issaad C, Pallardy M, et al. BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells. Blood. 1996;87(3):1113\u201322.","journal-title":"Blood"},{"key":"565_CR65","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10528-008-9142-1","volume":"46","author":"A Senkoylu","year":"2008","unstructured":"Senkoylu A, Yilmaz A, Ergun MA, et al. Effect of strontium Ranelate on hydrogen peroxide-induced apoptosis of CRL-11372 cells. Biochem Genet. 2008;46:197\u2013205.","journal-title":"Biochem Genet"},{"key":"565_CR66","doi-asserted-by":"publisher","unstructured":"Surace AEA, Hedrich CM. (2019). The role of epigenetics in autoimmune\/inflammatory disease. Front Immunol. 10:1525. https:\/\/doi.org\/10.3389\/fimmu. 2019.01525.","DOI":"10.3389\/fimmu"},{"key":"565_CR67","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","volume":"391","author":"DJ Veale","year":"2018","unstructured":"Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis. Lancet. 2018;391:2273\u201384.","journal-title":"Lancet"},{"key":"565_CR68","unstructured":"Gladman DD et al. Psoriatic arthritis. In: Harris ED, Budd RC, Firestein GS eds. Kelley\u2019s textbook of rheumatology. 7th edition. Philadelphia: W.B. Saunders, 2005:1155\u20131164."},{"key":"565_CR69","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:2095\u20136.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"565_CR70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/ard.2004.030775","volume":"64","author":"P Rahman","year":"2005","unstructured":"Rahman P, Elder JT. Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis. 2005;64(Suppl 2):37\u20139.","journal-title":"Ann Rheum Dis"},{"key":"565_CR71","doi-asserted-by":"publisher","first-page":"662047","DOI":"10.3389\/fmolb.2021.662047","volume":"8","author":"AL Carvalho","year":"2021","unstructured":"Carvalho AL, Hedrich CM. The molecular pathophysiology of psoriatic Arthritis-The complex interplay between genetic Predisposition, epigenetics Factors, and the Microbiome. Front Mol Biosci. 2021;8:662047. https:\/\/doi.org\/10.3389\/fmolb.2021.662047.","journal-title":"Front Mol Biosci"},{"key":"565_CR72","doi-asserted-by":"publisher","first-page":"e000867","DOI":"10.1136\/rmdopen-2018-000867","volume":"5","author":"PJ Mease","year":"2019","unstructured":"Mease PJ, Etzel CJ, Huster WJ, Muram TM, Armstrong AW, Lisse JR, et al. Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona registry. RMD Open. 2019;5:e000867. https:\/\/doi.org\/10.1136\/rmdopen-2018-000867.","journal-title":"RMD Open"},{"issue":"3","key":"565_CR73","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejr.2021.03.003","volume":"43","author":"DA ElSherbiny","year":"2021","unstructured":"ElSherbiny DA, Elsayed AM, El-Azizi NO, Ghalwash RA. Clinical and laboratory characteristics of psoriatic arthritis in a cohort of Egyptian patients. Egypt Rheumatologist. 2021;43(3):229\u201334.","journal-title":"Egypt Rheumatologist"},{"key":"565_CR74","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1365-2133.2008.09023.x","volume":"160","author":"K Reich","year":"2009","unstructured":"Reich K, Kruger K, Mossner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160:1040\u20137.","journal-title":"Br J Dermatol"},{"key":"565_CR75","first-page":"1065","volume":"51","author":"CP Rajendran","year":"2003","unstructured":"Rajendran CP, Ledge SG, Rani KP, Madhavan R. Psoriatic Arthritis JAPI. 2003;51:1065\u20138.","journal-title":"Psoriatic Arthritis JAPI"},{"key":"565_CR76","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0950-3579(05)80113-X","volume":"8","author":"I Kushner","year":"1994","unstructured":"Kushner I, Rzewnicki DL. The acute phase response: general aspects. Baillieres Clin Rheumatol. 1994;8:513\u201330.","journal-title":"Baillieres Clin Rheumatol"},{"key":"565_CR77","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0733-8651(03)00079-1","volume":"21","author":"PM Ridker","year":"2003","unstructured":"Ridker PM, Morrow DA. C-reactive protein, inflammation, and coronary risk. Cardiol Clin. 2003;21:315\u201325.","journal-title":"Cardiol Clin"},{"key":"565_CR78","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1365-2133.2008.08628.x","volume":"159","author":"B Strober","year":"2008","unstructured":"Strober B, Teller C, Yamauchi P, et al. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis. Br J Dermatol. 2008;159:322\u201330.","journal-title":"Br J Dermatol"},{"key":"565_CR79","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/rheumatology\/keq105","volume":"49","author":"V Chandran","year":"2010","unstructured":"Chandran V, Cook RJ, Edwin J, et al. Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology. 2010;49:1399\u2013405.","journal-title":"Rheumatology"},{"key":"565_CR80","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/ard.2009.122259","volume":"69","author":"M Schoels","year":"2010","unstructured":"Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS. Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis. 2010;69:1441\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"565_CR81","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5606\/tjr.2014.3400","volume":"29","author":"FG Yurdakul","year":"2014","unstructured":"Yurdakul FG, ESER F, Bodur H, GuL U, Gonul M, O\u011eUZ ID. Disease activity and related variables in patients with psoriatic arthritis. Arch Rheumatol. 2014;29(1):8\u201313.","journal-title":"Arch Rheumatol"},{"key":"565_CR82","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/sj.jid.5700008","volume":"126","author":"D Raj","year":"2006","unstructured":"Raj D, Brash DE, Grossman D. Keratinocyte apoptosis in epidermal development and disease. J Invest Dermatol. 2006;126:243\u201357.","journal-title":"J Invest Dermatol"},{"key":"565_CR83","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1046\/j.1523-1747.2003.12010.x","volume":"120","author":"AR Bowen","year":"2003","unstructured":"Bowen AR, Hanks AN, Allen SM, Alexander A, Diedrich MJ, Grossman D. Apoptosis regulators and responses in human melanocytic and keratinocytic cells. J Invest Dermatol. 2003;120:48\u201355.","journal-title":"J Invest Dermatol"},{"key":"565_CR84","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/sj.cdd.4401245","volume":"10","author":"C llombert-Blaise","year":"2003","unstructured":"llombert-Blaise C, Tamiji S, Mortier L, et al. Terminal differentiation of human epidermal keratinocytes involves mitochondria- and caspase-dependent cell pathway. Cell Death Differ. 2003;10:850\u20132.","journal-title":"Cell Death Differ"},{"key":"565_CR85","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0006-291X(02)02015-6","volume":"296","author":"AJ Chien","year":"2002","unstructured":"Chien AJ, Presland RB, Kuechle MK. Processing of native caspase-14 occurs at an atypical cleavage site in normal epidermal differentiation. Biochem Biophys Res Commun. 2002;296:911\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"565_CR86","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/sj.cdd.4402047","volume":"14","author":"M Lamkanfi","year":"2007","unstructured":"Lamkanfi M, Festjens N, Declercq W, Berghe TV, Vandenabeele P. Caspases in cell survival, proliferation and differentiation. Cell Death Differ. 2007;14:44\u201355.","journal-title":"Cell Death Differ"},{"key":"565_CR87","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrm1619","volume":"6","author":"E Candi","year":"2005","unstructured":"Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol. 2005;6:328\u201340.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"565_CR88","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0002-9440(10)62330-9","volume":"166","author":"L Eidsmo","year":"2005","unstructured":"Eidsmo L, Nylen S, Khamesipour A, Hedblad MA, Chiodi F, Akuffo H. The contribution of the Fas\/FasL apoptotic pathway in ulcer formation during leishmania major-induced cutaneous leishmaniasis. Am J Pathol. 2005;166:1099\u2013108.","journal-title":"Am J Pathol"},{"key":"565_CR89","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/sj.cdd.4400785","volume":"7","author":"S Lippens","year":"2000","unstructured":"Lippens S, Kockx M, Knaapen M, et al. Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death Differ. 2000;7:1218\u201324.","journal-title":"Cell Death Differ"},{"key":"565_CR90","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1046\/j.1523-1747.2002.19532.x","volume":"119","author":"M Rendl","year":"2002","unstructured":"Rendl M, Ban J, Mrass P, et al. Caspase-14 expression by epidermal keratinocytes is regulated by retinoids in a differentiation-associated manner. J Invest Dermatol. 2002;119:1150\u20135.","journal-title":"J Invest Dermatol"},{"key":"565_CR91","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1432-0436.2005.00046.x","volume":"73","author":"H Fischer","year":"2005","unstructured":"Fischer H, Rossiter H, Ghannadan M, et al. Caspase-14 but not caspase-3 is processed during the development of fetal mouse epidermis. Differentiation. 2005;73:406\u201313.","journal-title":"Differentiation"},{"key":"565_CR92","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.21495","volume":"45","author":"T Ben Moshe","year":"2007","unstructured":"Ben Moshe T, Barash H, Kang TB, et al. Role of caspase-8 in hepatocyte response to infection and injury in mice. Hepatology. 2007;45:1014\u201324.","journal-title":"Hepatology"},{"key":"565_CR93","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cytogfr.2008.04.012","volume":"19","author":"T Ben Moshe","year":"2008","unstructured":"Ben Moshe T, Kang T-B, Kovalenko A, et al. Cell-autonomous and non-cell-autonomous functions of caspase-8. Cytokine Growth Factor Rev. 2008;19:209\u201317.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"565_CR94","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1084\/jem.20090616","volume":"206","author":"A Kovalenko","year":"2009","unstructured":"Kovalenko A, Kim J-C, Kang T-B, et al. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J Exp Med. 2009;206(10):2161\u201377.","journal-title":"J Exp Med"},{"issue":"2Suppl","key":"565_CR95","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/S0190-9622(03)01134-4","volume":"49","author":"SL Mehlis","year":"2003","unstructured":"Mehlis SL, Gordon KB. The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol. 2003;49(2Suppl):S44\u201350.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"565_CR96","first-page":"530","volume":"59","author":"JNWN Barker","year":"1998","unstructured":"Barker JNWN. Psoriasis as a T cell- mediated autoimmune disease. HOSP MED. 1998;59(7):530\u20133.","journal-title":"HOSP MED"},{"issue":"3,2Suppl","key":"565_CR97","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/j.jaad.2005.10.057","volume":"54","author":"AA Gaspari","year":"2006","unstructured":"Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol. 2006;54(3,2Suppl):S67\u201380.","journal-title":"J Am Acad Dermatol"},{"key":"565_CR98","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/cmi.2012.15","volume":"9","author":"Y Cai","year":"2012","unstructured":"Cai Y, Fleming C, Yan J. New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol. 2012;9:302\u20139.","journal-title":"Cell Mol Immunol"},{"key":"565_CR99","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263\u201371.","journal-title":"Lancet"},{"key":"565_CR100","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11926-007-0071-5","volume":"9","author":"E Choy","year":"2007","unstructured":"Choy E. T cells in psoriatic arthritis. Curr Rheumatol Rep. 2007;9:437\u201341.","journal-title":"Curr Rheumatol Rep"},{"key":"565_CR101","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2174\/1568010043343868","volume":"3","author":"M Ozawa","year":"2004","unstructured":"Ozawa M, Aiba S. Immunopathogenesis of psoriasis. Curr Drug Targets Inflamm Allergy. 2004;3:137\u201344.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"565_CR102","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1001\/archderm.135.12.1495","volume":"135","author":"FP Murphy","year":"1999","unstructured":"Murphy FP, Coven TR, Burack LH, et al. Clinical clearing of psoriasis by 6-thioguanine correlates with cutaneous T-cell depletion via apoptosis: evidence for selective effects on activated T lymphocytes. Arch Dermatol. 1999;135:1495\u2013502.","journal-title":"Arch Dermatol"},{"key":"565_CR103","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2133.2006.07573.x","volume":"156","author":"T Simonart","year":"2007","unstructured":"Simonart T, Heenen M. T cell\/keratinocyte interactions in psoriasis: where is the trigger? Br J Dermatol. 2007;156:171\u20132.","journal-title":"Br J Dermatol"},{"key":"565_CR104","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/1529-0131(199907)42:7<1481::AID-ANR23>3.0.CO;2-E","volume":"42","author":"RJ Reece","year":"1999","unstructured":"Reece RJ, Canete JD, Parsons WJ, Emery P, Veale DJ. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum. 1999;42:1481\u20134.","journal-title":"Arthritis Rheum"},{"key":"565_CR105","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11926-012-0259-1","volume":"14","author":"H Rahimi","year":"2012","unstructured":"Rahimi H, Ritchlin CT. Altered bone biology in psoriatic arthritis. Curr Rheumatol Rep. 2012;14:349\u201357.","journal-title":"Curr Rheumatol Rep"},{"key":"565_CR106","doi-asserted-by":"publisher","first-page":"630620","DOI":"10.1155\/2013\/630620","volume":"2013","author":"T Yamamoto","year":"2013","unstructured":"Yamamoto T. Angiogenic and inflammatory properties of psoriatic arthritis. ISRN Dermatol. 2013;2013:630620.","journal-title":"ISRN Dermatol"},{"key":"565_CR107","first-page":"1434","volume":"35","author":"CT Ritchlin","year":"2008","unstructured":"Ritchlin CT. From skin to bone: translational perspectives on psoriatic disease. J Rheumatol. 2008;35:1434\u20137.","journal-title":"J Rheumatol"},{"key":"565_CR108","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/ard.2005.050963","volume":"65","author":"AW van Kuijk","year":"2006","unstructured":"van Kuijk AW, Reinders-Blankert P, Smeets TJ, Dijkmans BA, Tak PP. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis. 2006;65:1551\u20137.","journal-title":"Ann Rheum Dis"},{"key":"565_CR109","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00296-008-0534-7","volume":"28","author":"H Qingchun","year":"2008","unstructured":"Qingchun H, Runyue H, LiGang Y, et al. Comparison of the expression profile of apoptosis-associated genes in rheumatoid arthritis and osteoarthritis. Rheumatol Int. 2008;28:697\u2013701.","journal-title":"Rheumatol Int"},{"key":"565_CR110","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.2741\/3487","volume":"14","author":"KL Wood","year":"2009","unstructured":"Wood KL, Twigg HL 3rd, Doseff AI. Dysregulation of CD8\u2009+\u2009lymphocyte apoptosis, chronic disease and immune regulation. Front Biosci. 2009;14:3771\u201381.","journal-title":"Front Biosci"},{"key":"565_CR111","doi-asserted-by":"publisher","first-page":"621","DOI":"10.4049\/jimmunol.0803278","volume":"183","author":"JR Abreu","year":"2009","unstructured":"Abreu JR, Grabiec AM, Krausz S, et al. The presumed hyporesponsive behavior of rheumatoid arthritis T lymphocytes can be attributed to spontaneous ex vivo apoptosis rather than defects in T cell receptor signaling. J Immunol. 2009;183:621\u201330.","journal-title":"J Immunol"},{"key":"565_CR112","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10875-010-9429-y","volume":"30","author":"P Eggleton","year":"2010","unstructured":"Eggleton P, Harries LW, Alberigo G, et al. Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared to healthy controls. J Clin Immunol. 2010;30:649\u201358.","journal-title":"J Clin Immunol"},{"key":"565_CR113","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1152\/physiolgenomics.00004.2010","volume":"42","author":"U Ungethuem","year":"2010","unstructured":"Ungethuem U, Haeupl T, Witt H, et al. Molecular signatures and new candidates to target the pathogenesis of rheumatoid arthritis. Physiol Genomics. 2010;42:267\u201382.","journal-title":"Physiol Genomics"},{"key":"565_CR114","doi-asserted-by":"crossref","unstructured":"Yao A, Wang L, Qi F, Li J, Meng J, Jiang T, He Y, Lai W. Risk factors and early detection of joint damage in patients with psoriasis: a case\u2013control study. Int J Dermatol. 2024 Apr 29.","DOI":"10.1111\/ijd.17212"},{"key":"565_CR115","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10238-013-0252-7","volume":"14","author":"T Elango","year":"2014","unstructured":"Elango T, Dayalan H, Gnanaraj P, Malligarjunan H, Subramanian S. Impact of methotrexate on oxidative stress and apoptosis markers in psoriatic patients. Clin Experimental Med. 2014;14:431\u20137.","journal-title":"Clin Experimental Med"},{"issue":"11","key":"565_CR116","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1080\/14728222.2023.2285784","volume":"27","author":"M Staniszewska","year":"2023","unstructured":"Staniszewska M, Kie\u0142bowski K, Rusi\u0144ska K, Bakinowska E, Gromowska E, Pawlik A. Targeting cyclin-dependent kinases in rheumatoid arthritis and psoriasis\u2013a review of current evidence. Expert Opin Ther Targets. 2023;27(11):1097\u2013113.","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"565_CR117","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10787-022-01092-x","volume":"31","author":"A Makos","year":"2023","unstructured":"Makos A, Kuiper JH, Kehoe O, Amarasena R. Psoriatic arthritis: review of potential biomarkers predicting response to TNF inhibitors. Inflammopharmacology. 2023;31(1):77\u201387.","journal-title":"Inflammopharmacology"},{"key":"565_CR118","doi-asserted-by":"publisher","first-page":"662047","DOI":"10.3389\/fmolb.2021.662047","volume":"8","author":"AL Carvalho","year":"2021","unstructured":"Carvalho AL, Hedrich CM. The molecular pathophysiology of psoriatic arthritis\u2014the complex interplay between genetic predisposition, epigenetics factors, and the Microbiome. Front Mol Biosci. 2021;8:662047.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"565_CR119","doi-asserted-by":"publisher","first-page":"23","DOI":"10.35465\/31.1.2023.pp23-36","volume":"31","author":"AK Angelov","year":"2023","unstructured":"Angelov AK, Vasilev G, Yordanova A, Ivanova-Todorova E, Kyurkchiev D, Ivanova M. Elevated serum levels of TNF-\u03b1 and IL-17 in psoriatic and rheumatoid arthritis. Rheumatol (Bulgaria). 2023;31(1):23\u201336.","journal-title":"Rheumatol (Bulgaria)"},{"issue":"4","key":"565_CR120","first-page":"453","volume":"90","author":"AK Bhoi","year":"2024","unstructured":"Bhoi AK, Grover C, Singal A, Kashyap B. Serum levels of tumour necrosis factor (TNF-\u03b1) and interleukin-17 (IL-17) in patients with nail psoriasis: A cross-sectional study. Indian J Dermatol Venereol Leprol. 2024;90(4):453\u20137.","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["BMC Molecular and Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12860-026-00565-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12860-026-00565-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12860-026-00565-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:02:05Z","timestamp":1770840125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12860-026-00565-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,18]]},"references-count":120,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["565"],"URL":"https:\/\/doi.org\/10.1186\/s12860-026-00565-z","relation":{},"ISSN":["2661-8850"],"issn-type":[{"value":"2661-8850","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,18]]},"assertion":[{"value":"11 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol conformed to the ethical guidelines of the Declaration of Helsinki (2010). It was reviewed and approved by the ethics sub-committee of King Saud University, Riyadh, Saudi Arabia, under file ID: RRC-2019-14, dated: 22\/04\/2019. Each participant returned a signed informed consent form as a proof of consent to participate, before the start from our study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}